AMCOL International Corp. (ACO) Posts Q3 Operating EPS of $0.63, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts ACO Hot Sheet
Price: $45.74 --0%
Financial Fact:
Net income (loss) attributable to noncontrolling interests: -100K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net income (loss) attributable to noncontrolling interests: -100K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
AMCOL International Corp. (NYSE: ACO) reported Q3 EPS of $0.63, $0.14 better than the analyst estimate of $0.49. Net income was $0.60 per diluted share for the quarter. Revenue for the quarter came in at $248 million versus the consensus estimate of $265.67 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
